Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis

Inflammatory Bowel Diseases

Volumn 23, Issue 10, 2017, Pages 1702-1709

  Narula, Neeraj ^a   Kassam, Zain ^b   Yuan, Yuhong ^a   Colombel, Jean Frederic ^c   Ponsioen, Cyriel ^d   Reinisch, Walter ^a   Moayyedi, Paul ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Open Biome   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

fecal microbiota transplant; fecal transplant; inflammatory bowel disease; ulcerative colitis

Indexed keywords

MERCAPTOPURINE; PREDNISOLONE;

CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL ENDOSCOPY; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; META ANALYSIS; PRIORITY JOURNAL; QUALITY CONTROL; REMISSION; REVIEW; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; FECES; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

COLITIS, ULCERATIVE; FECAL MICROBIOTA TRANSPLANTATION; FECES; GASTROINTESTINAL MICROBIOME; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 85029739860     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000001228     Document Type: Review

References (39)

1. Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis. Lancet. 2017; 389:1756-1770.
2. Khan KJ, Ullman TA, Ford AC, et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011;106:661-673.
3. Chibbar R, Dieleman LA. Probiotics in the management of ulcerative colitis. J Clin Gastroenterol. 2015;49(suppl 1):S50-S55.
4. Kassam Z, Lee CH, Yuan Y, et al. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013;108:500-508.
5. Moayyedi P. Fecal transplantation: any real hope for inflammatory bowel disease? Curr Opin Gastroenterol. 2016;32:282-286.
6. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2014;8:1569-1581.
7. Scaldaferri F, Pecere S, Petito V, et al. Efficacy and mechanisms of action of fecal microbiota transplantation in ulcerative colitis: pitfalls and promises from a first meta-analysis. Transpl Proc. 2016;48:402-407.
8. Shi Y, Dong Y, Huang W, et al. Fecal microbiota transplantation for ulcerative colitis: a systematic review and meta-analysis. PLoS One. 2016;11:e0157259.
9. Sun D, Li W, Li S, et al. Fecal microbiota transplantation as a Novel therapy for ulcerative colitis: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95:e3765.
10. Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389:1218-1228.
11. Costello SW, Bryant R, Katsikeros R, et al. Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial. J Crohns Colitis. 2017;11(suppl 1):S23.
12. Shah SC, Colombel JF, Sands BE, et al. Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14:1245-1255.e8.
13. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
14. Ishikawa DOT, Haga K, Kodani T, et al. Combination therapy of fresh faecal microbial transplantation and antibiotics for ulcerative colitis. J Crohns Colitis. 2016;10:S335-S6
15. Cui B, Li P, Xu L, et al. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med. 2015; 13:298.
16. Grewal CSA, Mehta V, Mahajan R. Role of fecal microbiota transplantation in steroid dependant ulcerative colitis: a prospective observational study. J Gastroenterol. 2016;35(1 suppl):A39
17. Wei Y, Zhu W, Gong J, et al. Fecal microbiota transplantation improves the quality of Life in patients with inflammatory bowel disease. Gastroenterol Res Pract. 2015;2015:517597.
18. Ren R, Sun G, Yang Y, et al. A pilot study of treating ulcerative colitis with fecal microbiota transplantation [in Chinese]. Zhonghua Nei Ke Za Zhi. 2015;54:411-415.
19. Pai NPJ, Lee C. A randomized, placebo-controlled trial of fecal microbial transplantation for pediatric ulcerative colitis (pedifetch trial). J Pediatr Gastroenterol Nutr. 2016;63:S79-S80
20. Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149:102-109. e6.
21. Rossen NG, Fuentes S, van der Spek MJ, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149:110-108. e4.
22. Agrawal M, Aroniadis OC, Brandt LJ, et al. The long-term efficacy and safety of fecal microbiota transplant for recurrent, severe, and complicated clostridium difficile infection in 146 Elderly individuals. J Clin Gastroenterol. 2016;50:403-407.
23. Kelly CR, Kahn S, Kashyap P, et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology. 2015;149:223-237.
24. Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017;66: 569-580.
25. Smith M, Kassam Z, Edelstein C, et al. OpenBiome remains open to serve the medical community. Nat Biotechnol. 2014;32:867.
26. Osman MOB K, Stoltzner Z, Ling K, et al. Safety and efficacy of fecal microbiota transplantation for recurrent Clostridum difficile infection from an international public stool bank: results from a 2050-patient multicenter cohort. Open Forum Infect Dis. 2016;3(suppl 1):2120.
27. Dubois NL K, Osman M, Burns L, et al. Prospective assessment of donor eligibility for fecal microbiota transplantation at a public stool bank: results from the evaluation of 1387 candidate donors. Open Forum Infect Dis. 2015;2(suppl 1):962.
28. Youngster I, Mahabamunuge J, Systrom HK, et al. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection. BMC Med. 2016;14:134.
29. Allegretti JFM, Papa E, Elliott RJ. et al. Fecal microbiota transplantation delivered via oral capsules achieves microbial engraftment similar to traditional delivery modalities: safety, efficacy and engraftment results from a multi-center cluster randomized dose-finding study. Gastroenterology. 2016;150:S540.
30. Jalanka J, Salonen A, Salojarvi J, et al. Effects of bowel cleansing on the intestinal microbiota. Gut. 2015;64:1562-1568.
31. Harrell L, Wang Y, Antonopoulos D, et al. Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon. PLoS One. 2012;7:e32545.
32. Drago L, Toscano M, De Grandi R, et al. Persisting changes of intestinal microbiota after bowel lavage and colonoscopy. Eur J Gastroenterol Hepatol. 2016;28:532-537.
33. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent clostridium difficile-associated diarrhea. J Infect Dis. 2008;197:435-438.
34. Chu ND, Smith MB, Perrotta AR, et al. Profiling living bacteria informs preparation of fecal microbiota transplantations. PLoS One. 2017;12: e0170922.
35. Fischer MAJR, Smith M, Klank MJ, et al. A Multi-Center, cluster randomized dose-finding study of fecal microbiota transplantation capsules for recurrent Clostridum difficile infection. United Eur Gastroenterol J. 2015;3:561-571.
36. Osman MSZ; O'Brien K; Ling K, et al. Donor efficacy in fecal microbiota transplantation for recurrent Clostridum difficile: evidence from a 1999-patient cohort. Open Forum Infect Dis. 2016;3(suppl 1):841.
37. Vermeire S, Joossens M, Verbeke K, et al. Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease. J Crohns Colitis. 2016;10:387-394.
38. Norman JM, Handley SA, Baldridge MT, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell. 2015;160: 447-460.
39. Ott SJ, Kuhbacher T, Musfeldt M, et al. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol. 2008;43:831-841.